Medicare Enrolled

Dr. Joseph Womack, MD

Urology Physician · Texarkana, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5002 COWHORN CREEK RD, Texarkana, TX 75503
9036143000
In practice since 2005 (20 years)
NPI: 1003816901 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Womack from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Womack? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Womack

Dr. Joseph Womack is an urology physician in Texarkana, TX, with 20 years in practice. Based on federal Medicare data, Dr. Womack performed 4,178 Medicare services across 2,747 unique beneficiaries.

Between the years covered by Open Payments, Dr. Womack received a total of $1,860 from 31 pharmaceutical and/or device companies across 101 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Womack is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 29% volume in TX$ $1,860 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,178
Medicare services
Top 29% in TX for urology physician
2,747
Unique beneficiaries
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~209 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Urinalysis with microscopic exam937$3$28
Office visit, established patient (20-29 min)398$59$175
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant357$667$1,750
Office visit, established patient (30-39 min)308$88$244
Blood draw (venipuncture)237$8$20
Leuprolide acetate (for depot suspension), 7.5 mg186$132$440
Diagnostic exam of bladder and urethra using an endoscope181$167$445
PSA test (prostate cancer screening)174$18$79
Urine culture, bacterial identification163$8$42
Drug injection, under skin or into muscle139$10$42
Bladder ultrasound after voiding108$7$75
X-ray of abdomen, 1 view91$14$42
Injection, garamycin, gentamicin, up to 80 mg88$2$14
New patient office visit (45-59 min)83$109$315
Bacterial culture, aerobic78$8$40
Antibiotic sensitivity test75$8$58
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant67$972$2,280
Ultrasound scan of pelvic region through rectum61$103$350
Electronic assessment of bladder emptying56$5$225
Imaging of urinary tract following injection of a contrast agent49$19$40
Initial hospital admission, moderate complexity46$96$255
Blood creatinine level45$5$28
New patient office visit (30-44 min)32$65$215
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle30$26$63
Prostate cancer screening; prostate specific antigen test (psa)29$19$79
Limited ultrasound scan behind abdominal cavity24$40$215
Insertion of stent in ureter using an endoscope21$112$1,857
Biopsy of prostate gland20$181$495
Testosterone (hormone) level, total20$25$105
Psa (prostate specific antigen) measurement, free19$18$62
Simple insertion of temporary bladder tube15$44$225
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings14$25$445
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope14$234$975
Crushing of stone of ureter with insertion of stent using an endoscope13$306$2,365
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
12.4% medium
86.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,860
Total received (2018-2024)
Avg $266/year across 7 years
Bottom 37% in TX for urology physician
31
Companies
101
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,860 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$339
2023
$387
2022
$207
2021
$152
2020
$100
2019
$348
2018
$325

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$303
Astellas Pharma US Inc
$296
Teleflex LLC
$142
NeoTract Inc.
$139
Axonics, Inc.
$122
ABBVIE INC.
$110
Ferring Pharmaceuticals Inc.
$66
PROCEPT BioRobotics Corporation
$65
Blue Earth Diagnostics Limited
$60
Sumitomo Pharma America, Inc.
$54
AbbVie Inc.
$51
UROVANT SCIENCES INC
$47
Medtronic, Inc.
$47
ACCORD HEALTHCARE, INC.
$42
AbbVie, Inc.
$31
Accord Healthcare, Inc.
$27
180 Medical, Inc.
$24
Janssen Biotech, Inc.
$22
C. R. Bard, Inc. & Subsidiaries
$21
PFIZER INC.
$20
Allergan, Inc.
$19
Merck Sharp & Dohme Corporation
$18
Siemens Medical Solutions USA, Inc.
$18
Biocompatibles, Inc.
$17
Melinta Therapeutics, Inc.
$16
Cook Medical LLC
$15
UroGen Pharma, Inc.
$15
Avadel Specialty Pharmaceuticals, LLC
$15
Tolmar, Inc.
$14
Retrophin, Inc.
$14
Coloplast Corp
$11
Top 3 companies account for 39.9% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Axonics · Axumin · BOTOX · Bulkamid · CAMCEVI · COOK · ELIGARD · Erleada · GEMTESA · GENERAL BPH · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Rezum Generator · SELF-CATH · SKYLITE · SPACEOAR · SPEEDICATH · SpaceOAR System · UROLIFT · UroLift · UroLift System · Uroskop Omnia Max · VESICARE · VISUAL-ICE · Vabomere · Veozah · XTANDI · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $45 per 100 Medicare services performed
Looking for a urology physician in Texarkana?
Compare urology physicians in the Texarkana area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
7
Per 100K population
7.6
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Womack is a clinical cardiology specialist, with above-average Medicare volume (top 29% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Womack experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Womack performed 937 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Womack receive payments from pharmaceutical companies?
Yes. Dr. Womack received a total of $1,860 from 31 companies across 101 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Womack's costs compare to other urology physicians in Texarkana?
Dr. Womack's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Womack) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →